The Recall Desk

FDA (Drugs) recall action 89368

Teva Pharmaceuticals USA recalled 2 products on 2022-02-09

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2022-02-09
Critical
0
Units
224,604

Why these products were recalled

Mislabeling

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

1–2 of 2

  • LowFDA (Drugs)··2022-02-09

    Prescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals

    Teva Pharmaceuticals USA is recalling Mimvey (estradiol and norethindrone acetate) tablets nationwide due to mislabeling. The recall affects 6,430 cartons distributed throughout the USA.

    Product
    MIMVEY (ESTRADIOL AND NORETHINDRONE ACETATE)
    Category
    Distribution
    0 states
  • LowFDA (Drugs)··2022-02-09

    Mimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall

    Teva Pharmaceuticals USA is recalling Mimvey (estradiol and norethindrone acetate) tablets nationwide due to mislabeling on certain cartons. The recall affects 218,174 cartons distributed in the United States.

    Product
    MIMVEY (ESTRADIOL AND NORETHINDRONE ACETATE)
    Category
    Distribution
    0 states